The Antibody Industrial Symposium is a prestigious international congress jointly organized by the scientific society LabEx MAbImprove and the dynamic biotherapy industrial organization MabDesign. This event covers the latest advances and associated challenges in the field of therapeutic antibodies and their derivatives, recombinant proteins and other biomedicines, from R&D and into clinical phases.

This symposium isn’t just another conference; it’s a vibrant platform where researchers, industry leaders, medical professionals, and policymakers converge to explore the latest advancements in therapeutic antibodies and beyond. It features captivating keynote lectures, dynamic pitch talks unveiling innovative projects, and insightful industry presentations from leading pharmaceutical companies.

Spanning across 11 insightful sessions, this year’s program will explore the hottest trends in antibody research and development.

Moreover, AIS2026, offers invaluable networking opportunities, providing a platform for companies to showcase their pioneering products and technologies, as well as fostering high-impact business collaborations.

✨ What’s New in 2026

🔬 Exclusive Pre-Event by Evotec (June 29th, 2026)
“From Antibody Discovery to IND: Advancing Biologics in Oncology”
Kick off AIS with a high-level scientific session hosted by Evotec, offering deep insights into biologics development.
Learn more: aiscongress.com/agenda-pre-event

🏢 Exclusive INITS SMO Site Visit (June 29th, 2026)
Gain rare behind-the-scenes access to INITS SMO (Shared Manufacturing Organization), a 3,200 m² multiproduct and flexible GMP biomanufacturing facility.
Discover more: aiscongress.com/agenda-site-tour-inits-smo

🤝 AFSSI Connexions – Co-located Event
For the first time, AIS will host AFSSI Connexions at the same venue and time, creating a unique opportunity to connect with a broader ecosystem of innovative biotech service providers.
More info: www.afssi-connexions.fr